Lifebit partners with NIHR Cambridge Biomedical Research Centre to launch the CYNAPSE platform for next-generation genomics research
PR94220
LONDON, Jan. 25, 2022 /PRNewswire=KYODO JBN/ --
Lifebit today announces a long-term partnership where Lifebit's technology,
Lifebit CloudOS, will power a cloud-based Trusted Research Environment (TRE) to
serve as the scalable and secure data management and analysis platform for
researchers at the National Institute for Health Research (NIHR) Cambridge
Biomedical Research Centre (BRC).
Photo - https://mma.prnewswire.com/media/1732901/Lifebit.jpg
As one of the leading UK biomedical research organisations, the NIHR Cambridge
BRC maintains a secure source of fully consented clinico-genomic data from
patients with chronic diseases and cancer. This biomedical data holds huge
potential for health researchers to unlock discoveries on disease, supporting
recent breakthroughs such as the development of clinical algorithms to guide
precision cancer treatments (https://www.nature.com/articles/s43018-021-00200-0
).
With the launch of CYNAPSE, the NIHR Cambridge BRC joins a growing number of
research organisations who are standing up TREs that make use of Lifebit's
pioneering federated technology, designed to take researcher's computation and
analysis to where the data resides, to make sensitive biomedical data securely
accessible. Other examples include Genomics England (
) and the Hong Kong Genome Institute (
https://lifebit.ai/blog/lifebit-awarded-a-four-year-contract-for-hong-kongs-genome-project/
).
This news comes in the wake of an announcement of the DARE UK consortium effort
between Genomics England, NIHR Cambridge BRC, Eastern AHSN, Cambridge
University Health Partners and Lifebit that will see Lifebit's unique federated
technology bridge the TREs of these leading organisations.
"Lifebit is proud to be delivering this next generation federated research
platform, which will allow NIHR Cambridge BRC researchers to more effectively
collaborate at scale and drive a new wave of connected data here in the UK and
globally, accelerating research impact and advancements in patient care." said
Thorben Seeger, Lifebit CBDO.
For the full release, click here
(https://lifebit.ai/blog/nihr-cambridge-brc-partners-with-lifebit ).
About Lifebit Biotech, Ltd.
Lifebit builds enterprise data platforms for use by organisations with complex
and sensitive biomedical datasets. Lifebit's patented federated technology
securely unlocks access to biomedical data. From providing Trusted Research
Environments for national precision medicine programmes to enabling
pharmaceutical companies to discover new drug targets faster, Lifebit empowers
customers to transform how they leverage sensitive biomedical data.
About NIHR
The mission of the National Institute for Health Research (NIHR) is to improve
the health and wealth of the nation through research. We do this by:
-- Funding high quality, timely research that benefits the NHS, public
health and social care;
-- Investing in world-class expertise, facilities and a skilled delivery
workforce to translate discoveries into improved treatments and
services;
-- Partnering with patients, service users, carers and communities,
improving the relevance, quality and impact of our research;
-- Attracting, training and supporting the best researchers to tackle
complex health and social care challenges;
-- Collaborating with other public funders, charities and industry to help
shape a cohesive and globally competitive research system;
-- Funding applied global health research and training to meet the needs of
the poorest people in low and middle income countries.
NIHR is funded by the Department of Health and Social Care. Its work in low and
middle income countries is principally funded through UK Aid from the UK
government.
About NIHR Cambridge Biomedical Research Centre
Based within the most outstanding NHS and University partnerships in the
country, the Biomedical Research Centres are leaders in scientific translation.
Located on the Cambridge Biomedical Campus, they receive substantial levels of
funding from the National Institute for Health Research (NIHR) to translate
fundamental biomedical research into clinical research that benefits patients
and they are early adopters of new treatments.
SOURCE Lifebit Biotech
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。